Lia Kallenberger
Location
Zürich
Field of Study
DNA repair, synthetic lethality/viability, oncology, rare disease, neurodegeneration
Expertise
Cellular disease models and assays, CRISPR/Cas9
About
Scientist looking for a new challenge
I am a curious, driven Scientist experienced with a variety of cellular disease models, CRISPR/Cas9, target identification and validation, moving targets into drug discovery and paving the way to the clinic. I would love to be involved in building something exciting in a motivated team, help with advice or going back to the bench.
Social Media:
Skills
Bacterial Cell Culture
Cell Culture
Collaboration
Crispr
Early-stage Startups
FACS
FACS analysis
Fluorescence Microscopy
Immunofluorescence
Mammalian Cell Culture
Microscopy
Molecular & Cellular Biology
Neurodegeneration
Oncology
Rare Diseases
Real-Time Polymerase Chain Reaction (qPCR)
Startup Development
Western Blotting
Working with Investors
Open for
cofounder
fulltime
parttime
mentoring
Work Experience
ETHZ
2017-06 - 2019-09
Postdoctoral fellow
Zürich
fulltime
Investigating involvement of DNA repair pathways in physiological and pathological pathways such as antibody diversification, resistance to chemotherapy and modulation of DNA methylation patterns and gene expression.
Adrestia Therapeutics
2019-10 -
Senior Scientist
United Kingdom
fulltime
Project lead of target discovery and drug discovery projects in rare monogenetic diseases. Building cellular disease models and establishing cellular read-outs to be used in large whole-genome screens and target validation. Setting-up collaborative project plans with big pharma and CROs to reach milestones and progress projects towards the clinic.
Academic Experience
University of Zurich -
2014.01 - 2017.05
Philosophical Doctorate, PhD in Cancer Biology